功能性消化不良、脂肪肝、CA242增高,是怎么回事呢?

2019-01-28 王伯军 王伯军大夫谈消化

患者上腹胀闷多年,近来因情绪不佳导致病情加重,并恶心、厌油腻、胃口减退,多次胃镜示慢性非萎缩性胃炎,多次上腹B超示轻度脂肪肝,肝功能谷氨酰转肽酶轻度增高,CA242稍增高,是怎么一回事呢?

患者上腹胀闷多年,近来因情绪不佳导致病情加重,并恶心、厌油腻、口减退,多次镜示慢性非萎缩性胃炎,多次上腹B超示轻度脂肪肝,肝功能谷氨酰转肽酶轻度增高,CA242稍增高,是怎么一回事呢?

病 例

患者男,34岁,上腹胀闷多年,起床吃早饭后开始上腹闷,夜间不明显,情绪不好时更胀,不能喝凉的,无腹痛。半月前体检CA242超标,24.81 U/ml(正常参考值2 U/ml~20 U/ml),压力很大,一周后复查CA242只有10 U/ml。但此后上腹胀闷明显加重,厌油腻、恶心、嗳气、反酸、口舌不适、胃口减退、大便次数增多。右下胸偶有隐痛不适。

近三年三次胃镜(每年一次)都是:慢性非萎缩性胃炎。

多次上腹B超:轻度脂肪肝、右肾多发结石。

乙肝三系:HbsAb阳性、HbeAb阳性、HbcAb阳性;

丙肝抗体阴性、戍肝抗体IgG阳性、IgM阴性。

全腹CT平扫:右肾多发细小结石。

胸部CT平扫:气管憩室



请问:我的胃胀、恶心是什么原因,是胃还是肝、胰腺?还要做什么检查?

患者

回 复

已详细阅读了你发来的病史资料,你的情况考虑:功能性消化不良、脂肪肝、右肾多发结石。

你反复上腹胀闷很多年,时好时坏,情绪不好的时候更明显,最近因CA242增高的事情,病情加重,并且出现恶心、厌油腻,多次胃镜检查示慢性浅表性胃炎,B超示脂肪肝、肝功能只轻度异常,因此这些症状都是功能性消化不良的表现。

功能性消化不良是指一组无器质性病变或仅有慢性浅表性胃炎,以消化不良为表现的症候群,可反复或持续发作。分为二种类型:上腹疼痛综合征、餐后不适综合征,二型可重叠存在。

上腹疼痛综合征:

主要是上腹部不适、疼痛、上腹灼热感。

餐后不适综合征:

上腹胀闷、早饱,伴有嗳气、食欲下降、恶心等,常发生于餐后,或餐后加重。

功能性消化不良的原因有:胃动力障碍,内脏敏感性增高,胃底对食物的容受性舒张功能下降,幽门螺杆菌感染,心理因素等等。

从你的症状及目前的检查来看,功能性消化不良、餐后不适综合征诊断明确。

幽门螺杆菌你过去阳性,后经过治疗,呼气试验阴性、胃镜病理阴性,说明幽门螺杆菌已经根除。现在体检幽门螺杆菌抗体阳性,这是因为幽门螺杆菌感染后该抗体可以存在很长时间,在幽门螺杆菌根除后1年仍可以阳性。

你多次B超示脂肪肝,肝功能只谷氨酰转肽酶轻度增高,(胆红素只稍微增高一点没临床意义),因此脂肪肝诊断明确,虽然你没有提供身高、腰围、饮酒情况,但你体重83公斤、血脂偏高,很可能是非酒精性脂肪肝。乙肝三系示三抗体阳性,绝大多数已达临床治愈,你可以进一步做HBV-DNA以明确。戊肝抗体IgG阳性、IgM阴性,表示你过去感染过戊肝病毒,目前没有关系。

非酒精性脂肪肝大多无症状或症状很轻微,严重者可以有上腹胀闷、恶心、厌油腻、肝区刺痛的症状,这会肝功能明显异常。但你肝功能基本正常,因此你目前症状不能用非酒精性脂肪肝解释的。但你检查单中没有血清谷丙转氨酶和谷草转氨酶指标,建议你做一次完整肝功能检查,若这二项指标基本正常或只轻微增高,那么进一步证明你症状与脂肪肝无关。

CA242虽然是肿瘤指标,消化系统、肺及妇科肿瘤可以增高。但你CA242只稍微增高,这毫无意义,后面检测又正常,更可以排除恶性肿瘤了。可以说很多消化系统的良性疾病也可以轻度增高的,一般增高二倍以上才会有意义。你多次B超只脂肪肝、肺部CT支气管憩室、腹部CT平扫只右肾结石,因此大可以放心。你若想进一步明确,那就再做一次上腹部增强CT或磁共振吧。

根据你的情况可以明确诊断:功能性消化不良、脂肪肝。

功能性消化不良,与情绪有很大关系,你近段时间病情加重出现恶心也是与情绪有关。至于你所说右下胸偶尔疼痛,这可能与脂肪肝有关。

你已做了很多检查,没必要再做。如果近来大便确实不好,又没有做过结肠镜,可以做一次结肠镜检查,以了解大肠情况,这很有必要的。因为你这一年纪溃疡性结肠炎是比较容易发生。

可以说除了结肠镜以外不需要再做其它检查,你如果还不放心,建议可再做以下检查:

肝功能、HBV-DNA、上腹部增强CT或磁共振、结肠镜检查。

治疗建议

1.氟哌噻吨美利曲辛片早饭前半小时一粒每日一次,劳拉西泮片(每粒0.5 mg)早饭前中饭前半小时各半粒、睡前一粒,以调整胃肠神经、镇静、安眠治疗。

2.莫沙比利片1粒每日3次,复方消化酶2粒每日3次,双歧三联活菌胶囊3粒每日3次,均饭前半小时口服,以促进胃肠动力、助消化、调节肠道菌群。

注意:以上治疗2周后需根据病情调整药物种类和剂量。

3、至于脂肪肝主要是戒酒、减肥,控制体重,半年到1年内体重降到10%,不主张你现在药物治疗。

4.另外,我觉得你太过于焦虑,放松、适当锻炼、转移注意力很重要,不要把注意力集中在自己身上,尤其不要体会自己身体细微变化,把注意力转到感兴趣的事情上。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1915502, encodeId=2e89191550274, content=<a href='/topic/show?id=22a1328e7e5' target=_blank style='color:#2F92EE;'>#功能性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32877, encryptionId=22a1328e7e5, topicName=功能性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570f404, createdName=xlxchina, createdTime=Thu Feb 14 04:59:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1780514, encodeId=fba81e80514ae, content=<a href='/topic/show?id=f3c3394046' target=_blank style='color:#2F92EE;'>#CA242增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3940, encryptionId=f3c3394046, topicName=CA242增高)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/C4Qhy5XHSe503Qbjzc1UtDR83BCv66o6P2XRedX9ohsNGa3uEVicFFk2qkuX5zBSmpicepFySBrwoYknhqMdKmtw/132, createdBy=1aca2500179, createdName=12498d2fm51(暂无昵称), createdTime=Sat Feb 16 08:59:00 CST 2019, time=2019-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561621, encodeId=fb981561621bf, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Wed Jan 30 07:59:00 CST 2019, time=2019-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567630, encodeId=3183156e630b9, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Wed Jan 30 07:59:00 CST 2019, time=2019-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1602847, encodeId=1507160284e48, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3936, encryptionId=e0b5393680, topicName=CA2)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03ab18968787, createdName=TZF0810, createdTime=Wed Jan 30 07:59:00 CST 2019, time=2019-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1780513, encodeId=83d81e805131c, content=<a href='/topic/show?id=d13e393911' target=_blank style='color:#2F92EE;'>#CA242#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3939, encryptionId=d13e393911, topicName=CA242)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/3239AC2A9C7E6019A0BC3C0489A21F7A/100, createdBy=c6a52500178, createdName=41514487@qq.com, createdTime=Thu Jan 09 03:59:00 CST 2020, time=2020-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359446, encodeId=42543594465a, content=好文,值得点赞!认真学习了,把经验应用于实践,为患者解除病痛。, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRuUXgacXpPeW0x8Z3Qr9c3I2kTic4ZIpR29iaftYgkjRcbv982icYMtqANBPYBgPnOia6mVtX76qMXuc/0, createdBy=ebe61630855, createdName=1dd8a7c5m95(暂无匿称), createdTime=Mon Jan 28 17:18:49 CST 2019, time=2019-01-28, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1915502, encodeId=2e89191550274, content=<a href='/topic/show?id=22a1328e7e5' target=_blank style='color:#2F92EE;'>#功能性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32877, encryptionId=22a1328e7e5, topicName=功能性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570f404, createdName=xlxchina, createdTime=Thu Feb 14 04:59:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1780514, encodeId=fba81e80514ae, content=<a href='/topic/show?id=f3c3394046' target=_blank style='color:#2F92EE;'>#CA242增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3940, encryptionId=f3c3394046, topicName=CA242增高)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/C4Qhy5XHSe503Qbjzc1UtDR83BCv66o6P2XRedX9ohsNGa3uEVicFFk2qkuX5zBSmpicepFySBrwoYknhqMdKmtw/132, createdBy=1aca2500179, createdName=12498d2fm51(暂无昵称), createdTime=Sat Feb 16 08:59:00 CST 2019, time=2019-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561621, encodeId=fb981561621bf, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Wed Jan 30 07:59:00 CST 2019, time=2019-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567630, encodeId=3183156e630b9, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Wed Jan 30 07:59:00 CST 2019, time=2019-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1602847, encodeId=1507160284e48, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3936, encryptionId=e0b5393680, topicName=CA2)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03ab18968787, createdName=TZF0810, createdTime=Wed Jan 30 07:59:00 CST 2019, time=2019-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1780513, encodeId=83d81e805131c, content=<a href='/topic/show?id=d13e393911' target=_blank style='color:#2F92EE;'>#CA242#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3939, encryptionId=d13e393911, topicName=CA242)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/3239AC2A9C7E6019A0BC3C0489A21F7A/100, createdBy=c6a52500178, createdName=41514487@qq.com, createdTime=Thu Jan 09 03:59:00 CST 2020, time=2020-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359446, encodeId=42543594465a, content=好文,值得点赞!认真学习了,把经验应用于实践,为患者解除病痛。, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRuUXgacXpPeW0x8Z3Qr9c3I2kTic4ZIpR29iaftYgkjRcbv982icYMtqANBPYBgPnOia6mVtX76qMXuc/0, createdBy=ebe61630855, createdName=1dd8a7c5m95(暂无匿称), createdTime=Mon Jan 28 17:18:49 CST 2019, time=2019-01-28, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1915502, encodeId=2e89191550274, content=<a href='/topic/show?id=22a1328e7e5' target=_blank style='color:#2F92EE;'>#功能性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32877, encryptionId=22a1328e7e5, topicName=功能性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570f404, createdName=xlxchina, createdTime=Thu Feb 14 04:59:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1780514, encodeId=fba81e80514ae, content=<a href='/topic/show?id=f3c3394046' target=_blank style='color:#2F92EE;'>#CA242增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3940, encryptionId=f3c3394046, topicName=CA242增高)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/C4Qhy5XHSe503Qbjzc1UtDR83BCv66o6P2XRedX9ohsNGa3uEVicFFk2qkuX5zBSmpicepFySBrwoYknhqMdKmtw/132, createdBy=1aca2500179, createdName=12498d2fm51(暂无昵称), createdTime=Sat Feb 16 08:59:00 CST 2019, time=2019-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561621, encodeId=fb981561621bf, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Wed Jan 30 07:59:00 CST 2019, time=2019-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567630, encodeId=3183156e630b9, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Wed Jan 30 07:59:00 CST 2019, time=2019-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1602847, encodeId=1507160284e48, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3936, encryptionId=e0b5393680, topicName=CA2)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03ab18968787, createdName=TZF0810, createdTime=Wed Jan 30 07:59:00 CST 2019, time=2019-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1780513, encodeId=83d81e805131c, content=<a href='/topic/show?id=d13e393911' target=_blank style='color:#2F92EE;'>#CA242#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3939, encryptionId=d13e393911, topicName=CA242)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/3239AC2A9C7E6019A0BC3C0489A21F7A/100, createdBy=c6a52500178, createdName=41514487@qq.com, createdTime=Thu Jan 09 03:59:00 CST 2020, time=2020-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359446, encodeId=42543594465a, content=好文,值得点赞!认真学习了,把经验应用于实践,为患者解除病痛。, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRuUXgacXpPeW0x8Z3Qr9c3I2kTic4ZIpR29iaftYgkjRcbv982icYMtqANBPYBgPnOia6mVtX76qMXuc/0, createdBy=ebe61630855, createdName=1dd8a7c5m95(暂无匿称), createdTime=Mon Jan 28 17:18:49 CST 2019, time=2019-01-28, status=1, ipAttribution=)]
    2019-01-30 liuxiaona
  4. [GetPortalCommentsPageByObjectIdResponse(id=1915502, encodeId=2e89191550274, content=<a href='/topic/show?id=22a1328e7e5' target=_blank style='color:#2F92EE;'>#功能性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32877, encryptionId=22a1328e7e5, topicName=功能性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570f404, createdName=xlxchina, createdTime=Thu Feb 14 04:59:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1780514, encodeId=fba81e80514ae, content=<a href='/topic/show?id=f3c3394046' target=_blank style='color:#2F92EE;'>#CA242增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3940, encryptionId=f3c3394046, topicName=CA242增高)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/C4Qhy5XHSe503Qbjzc1UtDR83BCv66o6P2XRedX9ohsNGa3uEVicFFk2qkuX5zBSmpicepFySBrwoYknhqMdKmtw/132, createdBy=1aca2500179, createdName=12498d2fm51(暂无昵称), createdTime=Sat Feb 16 08:59:00 CST 2019, time=2019-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561621, encodeId=fb981561621bf, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Wed Jan 30 07:59:00 CST 2019, time=2019-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567630, encodeId=3183156e630b9, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Wed Jan 30 07:59:00 CST 2019, time=2019-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1602847, encodeId=1507160284e48, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3936, encryptionId=e0b5393680, topicName=CA2)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03ab18968787, createdName=TZF0810, createdTime=Wed Jan 30 07:59:00 CST 2019, time=2019-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1780513, encodeId=83d81e805131c, content=<a href='/topic/show?id=d13e393911' target=_blank style='color:#2F92EE;'>#CA242#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3939, encryptionId=d13e393911, topicName=CA242)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/3239AC2A9C7E6019A0BC3C0489A21F7A/100, createdBy=c6a52500178, createdName=41514487@qq.com, createdTime=Thu Jan 09 03:59:00 CST 2020, time=2020-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359446, encodeId=42543594465a, content=好文,值得点赞!认真学习了,把经验应用于实践,为患者解除病痛。, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRuUXgacXpPeW0x8Z3Qr9c3I2kTic4ZIpR29iaftYgkjRcbv982icYMtqANBPYBgPnOia6mVtX76qMXuc/0, createdBy=ebe61630855, createdName=1dd8a7c5m95(暂无匿称), createdTime=Mon Jan 28 17:18:49 CST 2019, time=2019-01-28, status=1, ipAttribution=)]
    2019-01-30 liuxiaona
  5. [GetPortalCommentsPageByObjectIdResponse(id=1915502, encodeId=2e89191550274, content=<a href='/topic/show?id=22a1328e7e5' target=_blank style='color:#2F92EE;'>#功能性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32877, encryptionId=22a1328e7e5, topicName=功能性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570f404, createdName=xlxchina, createdTime=Thu Feb 14 04:59:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1780514, encodeId=fba81e80514ae, content=<a href='/topic/show?id=f3c3394046' target=_blank style='color:#2F92EE;'>#CA242增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3940, encryptionId=f3c3394046, topicName=CA242增高)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/C4Qhy5XHSe503Qbjzc1UtDR83BCv66o6P2XRedX9ohsNGa3uEVicFFk2qkuX5zBSmpicepFySBrwoYknhqMdKmtw/132, createdBy=1aca2500179, createdName=12498d2fm51(暂无昵称), createdTime=Sat Feb 16 08:59:00 CST 2019, time=2019-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561621, encodeId=fb981561621bf, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Wed Jan 30 07:59:00 CST 2019, time=2019-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567630, encodeId=3183156e630b9, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Wed Jan 30 07:59:00 CST 2019, time=2019-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1602847, encodeId=1507160284e48, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3936, encryptionId=e0b5393680, topicName=CA2)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03ab18968787, createdName=TZF0810, createdTime=Wed Jan 30 07:59:00 CST 2019, time=2019-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1780513, encodeId=83d81e805131c, content=<a href='/topic/show?id=d13e393911' target=_blank style='color:#2F92EE;'>#CA242#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3939, encryptionId=d13e393911, topicName=CA242)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/3239AC2A9C7E6019A0BC3C0489A21F7A/100, createdBy=c6a52500178, createdName=41514487@qq.com, createdTime=Thu Jan 09 03:59:00 CST 2020, time=2020-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359446, encodeId=42543594465a, content=好文,值得点赞!认真学习了,把经验应用于实践,为患者解除病痛。, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRuUXgacXpPeW0x8Z3Qr9c3I2kTic4ZIpR29iaftYgkjRcbv982icYMtqANBPYBgPnOia6mVtX76qMXuc/0, createdBy=ebe61630855, createdName=1dd8a7c5m95(暂无匿称), createdTime=Mon Jan 28 17:18:49 CST 2019, time=2019-01-28, status=1, ipAttribution=)]
    2019-01-30 TZF0810
  6. [GetPortalCommentsPageByObjectIdResponse(id=1915502, encodeId=2e89191550274, content=<a href='/topic/show?id=22a1328e7e5' target=_blank style='color:#2F92EE;'>#功能性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32877, encryptionId=22a1328e7e5, topicName=功能性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570f404, createdName=xlxchina, createdTime=Thu Feb 14 04:59:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1780514, encodeId=fba81e80514ae, content=<a href='/topic/show?id=f3c3394046' target=_blank style='color:#2F92EE;'>#CA242增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3940, encryptionId=f3c3394046, topicName=CA242增高)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/C4Qhy5XHSe503Qbjzc1UtDR83BCv66o6P2XRedX9ohsNGa3uEVicFFk2qkuX5zBSmpicepFySBrwoYknhqMdKmtw/132, createdBy=1aca2500179, createdName=12498d2fm51(暂无昵称), createdTime=Sat Feb 16 08:59:00 CST 2019, time=2019-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561621, encodeId=fb981561621bf, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Wed Jan 30 07:59:00 CST 2019, time=2019-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567630, encodeId=3183156e630b9, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Wed Jan 30 07:59:00 CST 2019, time=2019-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1602847, encodeId=1507160284e48, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3936, encryptionId=e0b5393680, topicName=CA2)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03ab18968787, createdName=TZF0810, createdTime=Wed Jan 30 07:59:00 CST 2019, time=2019-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1780513, encodeId=83d81e805131c, content=<a href='/topic/show?id=d13e393911' target=_blank style='color:#2F92EE;'>#CA242#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3939, encryptionId=d13e393911, topicName=CA242)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/3239AC2A9C7E6019A0BC3C0489A21F7A/100, createdBy=c6a52500178, createdName=41514487@qq.com, createdTime=Thu Jan 09 03:59:00 CST 2020, time=2020-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359446, encodeId=42543594465a, content=好文,值得点赞!认真学习了,把经验应用于实践,为患者解除病痛。, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRuUXgacXpPeW0x8Z3Qr9c3I2kTic4ZIpR29iaftYgkjRcbv982icYMtqANBPYBgPnOia6mVtX76qMXuc/0, createdBy=ebe61630855, createdName=1dd8a7c5m95(暂无匿称), createdTime=Mon Jan 28 17:18:49 CST 2019, time=2019-01-28, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1915502, encodeId=2e89191550274, content=<a href='/topic/show?id=22a1328e7e5' target=_blank style='color:#2F92EE;'>#功能性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32877, encryptionId=22a1328e7e5, topicName=功能性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=570f404, createdName=xlxchina, createdTime=Thu Feb 14 04:59:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1780514, encodeId=fba81e80514ae, content=<a href='/topic/show?id=f3c3394046' target=_blank style='color:#2F92EE;'>#CA242增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3940, encryptionId=f3c3394046, topicName=CA242增高)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/C4Qhy5XHSe503Qbjzc1UtDR83BCv66o6P2XRedX9ohsNGa3uEVicFFk2qkuX5zBSmpicepFySBrwoYknhqMdKmtw/132, createdBy=1aca2500179, createdName=12498d2fm51(暂无昵称), createdTime=Sat Feb 16 08:59:00 CST 2019, time=2019-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561621, encodeId=fb981561621bf, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Wed Jan 30 07:59:00 CST 2019, time=2019-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567630, encodeId=3183156e630b9, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Wed Jan 30 07:59:00 CST 2019, time=2019-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1602847, encodeId=1507160284e48, content=<a href='/topic/show?id=e0b5393680' target=_blank style='color:#2F92EE;'>#CA2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3936, encryptionId=e0b5393680, topicName=CA2)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03ab18968787, createdName=TZF0810, createdTime=Wed Jan 30 07:59:00 CST 2019, time=2019-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1780513, encodeId=83d81e805131c, content=<a href='/topic/show?id=d13e393911' target=_blank style='color:#2F92EE;'>#CA242#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3939, encryptionId=d13e393911, topicName=CA242)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/3239AC2A9C7E6019A0BC3C0489A21F7A/100, createdBy=c6a52500178, createdName=41514487@qq.com, createdTime=Thu Jan 09 03:59:00 CST 2020, time=2020-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359446, encodeId=42543594465a, content=好文,值得点赞!认真学习了,把经验应用于实践,为患者解除病痛。, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRuUXgacXpPeW0x8Z3Qr9c3I2kTic4ZIpR29iaftYgkjRcbv982icYMtqANBPYBgPnOia6mVtX76qMXuc/0, createdBy=ebe61630855, createdName=1dd8a7c5m95(暂无匿称), createdTime=Mon Jan 28 17:18:49 CST 2019, time=2019-01-28, status=1, ipAttribution=)]
    2019-01-28 1dd8a7c5m95(暂无匿称)

    好文,值得点赞!认真学习了,把经验应用于实践,为患者解除病痛。

    0

相关资讯

艾滋病功能性治愈香山科学会议在北京召开

4月27日至28日,“艾滋病功能性治愈”香山科学会议在北京召开。来自国内外艾滋病临床和基础研究领域的50位顶级专家齐聚一堂,针对艾滋病治愈的研究进展和挑战等前沿问题展开深入研讨。

Nat Biotechnol:华人学者开启DNA甲基化在微生物群落研究中功能性的探索丨Nat Biotech

BioArt按:微生物群落在人类健康和疾病中的重要作用越来越被人们重视,很多检测分析的方法被广泛应用,但是目前仍然存在很大的挑战。之前的技术很好的利用到了微生物基因组的序列信息,而最新的这项研究第一次提出微生物基因组中广泛存在、却很大程度上被忽视的表观遗传学信息(DNA 甲基化修饰)可以被有效的利用于微生物群落宏基因组的研究。日前,来自西奈山伊坎医学院(Icahn School of Medici

Methods Mol Biol:从人诱导的多能干细胞产生功能性视网膜色素上皮细胞综述

德国雷根斯堡雷根斯堡大学医院眼科的Brandl C近日在Methods Mol Biol杂志上发表了一篇综述文章。在这篇文章中,作者详细描述了iPSC衍生的RPE单层细胞诱导过程,对它们的增殖和低温保存的方案也进行了讨论。同时,通过测量上皮抗性能力,来对功能性细胞分化进行监测。

英国剑桥大学科学家培育出功能性人工胆管

胆管是输送胆汁的管道。消化食物时,储存在胆囊里的胆汁通过它流入十二指肠。英国剑桥大学科学家在3日出版的《自然·医学》杂志发表论文称,他们在实验室培育出了3D胆管细胞结构,并移植进实验鼠体内发育成功能性胆管。这一人工胆管领域的重大进展,未来可取代肝移植,治疗肝病患儿。剑桥大学教授卢多维奇·瓦利耶带领实验团队,从人体中提取了健康的胆管细胞,在实验室培育成被称为“胆管类器官”的功能性3D结构。当移植进实

他是慢性胃炎还是功能性消化不良?

张先生,43岁。患有慢性胃病多年,近几年来常有上腹饱胀、嗳气、打嗝、烧心、反酸等症状,少量进食就有上腹饱胀感,时好时坏,多次到医院B超检查肝胆胰脾未发现异常,肝肾功能正常,多次胃镜检查诊断为“慢性浅表性胃炎’’(现在称为:慢性非萎缩性胃炎)。也无糖尿病、慢性肝炎等病史。

Cell Rep:科学家宣布艾滋病可以实现“功能性治愈”,动物试验已成功!

斯克里普斯研究所的研究人员们发现了一种完全不同的方法来治疗艾滋病毒感染。科学家们表明,新型化合物可以在慢性感染过程中,有效抑制病毒,并防止病毒反弹,即使是对受到强烈刺激的感染细胞也有着积极影响。